EUVIMEDEUVIMED entdecken
Kohortenstudie

Antibiotic Duration After Debridement and Implant Retention for Early Postoperative Spinal Implant Infections: A Multicenter Cohort Study

Don Bambino Geno Tai iD, Emily Poehlein, Jessica C O'Neil, Sandra B Nelson iD, Aaron J Tande iD, Daniela De Lima Corvino iD, Alaina S Ritter iD, Jenny Aronson iD, Laura Certain, Daisuke Furukawa iD, Alexander M Tatara iD, Cynthia L Green iD und 6 weitere

Clinical Infectious Diseases · 05.05.2026

DOI: 10.1093/cid/ciag300 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 05.05.2026. Verfasst von Don Bambino Geno Tai und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases and International Medicine, University of Minnesota Medical School, Minneapolis, MN, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: National Institutes of Health, The Trauma Research and Combat Casualty Care Collaborative.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Postoperative spinal implant infections (PSIIs) are a serious complication of instrumented spinal fusion. Although debridement with implant retention is standard for early infection, the optimal duration of antimicrobial therapy remains uncertain.

Methods

We conducted a multicenter retrospective cohort study across 10 US academic centers, including adults with early PSII (≤90 days after fusion surgery) from 2017 to 2021. We excluded patients who experienced treatment failure within 6 weeks of debridement. The primary outcome was treatment failure. Antibiotic therapy effect was analyzed as a time-varying exposure using adjusted Cox proportional hazards models. Secondary analyses included 12-week landmark and clone-censor-weighted models to compare durations ≤ 12 weeks versus >12 weeks.

Results

A total of 116 patients out of 499 (23.2%) experienced treatment failure during a median follow-up of 3.2 years. Among patients who remain failure-free 6 weeks from debridement, being on antibiotics was not associated with treatment failure (adjusted hazard ratio [aHR] 0.71; 95% CI .48–1.07; P = .10). In a 12-week landmark analysis limited to 359 patients who were not on indefinite suppressive antibiotic therapy, treatment durations > 12 weeks did not significantly reduce the risk of failure (aHR 1.01; 95% CI .62–1.64; P = .99). Results were consistent in the clone-censor-weight sensitivity analysis (aHR 0.85; 95% CI .62–1.16; P = .30).

Conclusions

Prolonged antibiotic therapy was not associated with improved outcomes in early PSII managed with debridement and implant retention. These results support shorter, individualized antibiotic courses in patients with adequate surgical source control.

Schlagwörter

Stichwörter der Autor:innen

Antibiotic durationDebridement and implant retentionMusculoskeletal infectionPostoperative spinal implant infectionantimicrobial stewardship

Autor:innen und Institutionen

  • Division of Infectious Diseases and International Medicine, University of Minnesota Medical School, Minneapolis, MN, USA.
  • Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, USA.
  • Division of Infectious Diseases, University of Pennsylvania, Philadelphia, PA, USA.
  • Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.
  • Department of Medicine; Harvard Medical School, Boston MA, USA.
  • Division of Public Health, Infectious Diseases and Occupational Medicine, Mayo Clinic, Rochester, MN, USA.

ORCID-Profile: Don Bambino Geno Tai, Sandra B Nelson, Aaron J Tande, Daniela De Lima Corvino, Alaina S Ritter, Jenny Aronson, Daisuke Furukawa, Alexander M Tatara, Cynthia L Green, Daniel G Tobert, Jessica Seidelman

Förderung

  • National Institutes of Health
  • The Trauma Research and Combat Casualty Care Collaborative

Zitieren

APA

Tai, D. B. G., Poehlein, E., O'Neil, J. C., Nelson, S. B., Tande, A. J., Corvino, D. L., Ritter, A. S., Aronson, J., Certain, L., Furukawa, D., Tatara, A. M., Green, C. L., Abdalla, T., Fleece, M. E., Tobert, D. G., Erickson, M., Seidelman, J., & SPIRIT Team (2026). Antibiotic Duration After Debridement and Implant Retention for Early Postoperative Spinal Implant Infections: A Multicenter Cohort Study. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag300

Vancouver

Tai DBG, Poehlein E, O'Neil JC, Nelson SB, Tande AJ, Corvino DL, et al. Antibiotic Duration After Debridement and Implant Retention for Early Postoperative Spinal Implant Infections: A Multicenter Cohort Study. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciag300

BibTeX
@article{Tai2026,
  author = {Tai, Don Bambino Geno and Poehlein, Emily and O'Neil, Jessica C and Nelson, Sandra B and Tande, Aaron J and Corvino, Daniela De Lima and Ritter, Alaina S and Aronson, Jenny and Certain, Laura and Furukawa, Daisuke and Tatara, Alexander M and Green, Cynthia L and Abdalla, Tarek and Fleece, Molly E and Tobert, Daniel G and Erickson, Melissa and Seidelman, Jessica and SPIRIT Team, SPIRIT Team},
  title = {Antibiotic Duration After Debridement and Implant Retention for Early Postoperative Spinal Implant Infections: A Multicenter Cohort Study},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  doi = {10.1093/cid/ciag300}
}
Kostenlos starten →